3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
11
Osteoporosis
5
Prostatic Neoplasms
4
Neoplasms
4
Multiple Myeloma
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Testicular Neoplasms
1
Smoldering Multiple Myeloma
1
Regional Osteoporosis as a Result of Chemotherapy
1
Recurrence
1
Polycystic Ovary Syndrome
1
Paraganglioma, Extra-Adrenal
1
Pain
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Menstruation Disturbances
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lymphedema
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Depression
1
Cicatrix
1
Cardiovascular Diseases
1
Carcinoma, Transitional Cell
1
Interventions
Peripheral Blood Stem Cell Transplantation
4
Epoetin Alfa
3
Darbepoetin alfa
3
Cyclophosphamide
3
liposomal amphotericin B
2
fludarabine phosphate
2
Microarray Analysis
2
Methylprednisolone
2
Interferon-alpha
2
In Situ Hybridization, Fluorescence
2
Filgrastim
2
Cytogenetic Analysis
2
Cyclosporine
2
Caspofungin
2
Bortezomib
2
Antilymphocyte Serum
2
tanespimycin
1
siltuximab
1
pyroxamide
1
piperine
1
ibrutinib
1
ferrous sulfate
1
ferric gluconate
1
aldesleukin
1
Whole-Body Irradiation
1
Watchful Waiting
1
Urination
1
Topotecan
1
Therapeutics
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Monoclonal Gammopathy of Undetermined Significance
×
Absorptiometry, Photon
×
Clear all
NCT03951220
2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
67 enrolled
24 charts